Evaluation of ZestiVits in Children and Adults on a Ketogenic or Restricted Therapeutic Diet
NCT ID: NCT02825758
Last Updated: 2024-02-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2017-02-17
2018-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acceptability of Zinc-fortified Lipid-based Nutrient Supplements
NCT00944814
Zinc Absorption From SQ-LNS With and Without Phytase
NCT02668133
Effectiveness of a Micronutrient Supplement to Lower Plasma Homocysteine MDEG2 Pilot Supplementation Trial
NCT03431597
Evaluation of Calcium, Vitamin D, Magnesium, and Zinc Absorption in Children
NCT00868738
Assessment of a New Food Product in Metabolically at Risk Children
NCT03175003
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Qualitative assessments from subject questionnaires that allow evaluation of the acceptability and ease of use of the study product.
* Collection of daily data about the gastro-intestinal tolerance of the study product.
* Collection of daily data about compliance with the study product i.e. actual versus prescribed intake.
* Improve quality of life by increasing range of products available for use in a ketogenic or restricted therapeutic diet.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ZestiVits
Supplement for use in ketogenic and restricted therapeutic diets, from the age of 11.
Daily use for 7 days. Daily intake level for each subject will be determined and prescribed by a dietitian.
ZestiVits
The study product is a low-carbohydrate, orange flavour, vitamin, mineral and trace element (micronutrient) supplement for use in ketogenic and restricted therapeutic diets, for children aged from 11 years of age and adults.
The recommended dosage of the study product for each subject will be determined and prescribed by a dietitian. This will be based on individual requirements for micronutrient supplementation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ZestiVits
The study product is a low-carbohydrate, orange flavour, vitamin, mineral and trace element (micronutrient) supplement for use in ketogenic and restricted therapeutic diets, for children aged from 11 years of age and adults.
The recommended dosage of the study product for each subject will be determined and prescribed by a dietitian. This will be based on individual requirements for micronutrient supplementation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. On a ketogenic or restricted therapeutic diet with good compliance
3. Aged 11 years and over
4. Has a requirement for a micronutrient supplement
5. Written informed consent by subject or parent/carer
Exclusion Criteria
2. Use of additional micronutrient supplements during the study period unless clinically indicated and prescribed by the investigator (must be recorded in patient case record file)
11 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vitaflo International, Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gisela Wilcox
Role: PRINCIPAL_INVESTIGATOR
Northern Care Alliance NHS Foundation Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bristol Royal Hospital for Children
Bristol, Avon, United Kingdom
Salford Royal NHS Foundation Trust
Salford, Greater Manchester, United Kingdom
Leeds Children's Hospital
Leeds, West Yorkshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
209722
Identifier Type: OTHER
Identifier Source: secondary_id
MCT-Zest-14/01/2016-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.